SEC Tracker
Get the app

CymaBay Therapeutics

Hans Von Emster Konrad (Director) plans to sell 15,921 shares, about $249,675

Form
144
Filed
Importance
Routine
Document
Form 144
  1. Approximate sale date: Sep 29, 2023
  2. Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
  3. Shares acquired by: Stock Option Exercise
  4. 10b5-1 plan adopted: Jun 30, 2023

All of Hans Von Emster Konrad's insider filings, holdings and planned sales

Form 4s that likely executed this notice (SEC Tracker's match by person, company, dates and shares):

  • Sold 15,921 shares at $15.68 on Sep 29, 2023 · Form 4

Written from the Form 144 on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when CymaBay Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2834) and public float not reported.

  1. Acura Pharmaceuticals ACUR
  2. Ayala Pharmaceuticals ADXS
  3. Ampio Pharmaceuticals AMPE
  4. Alterity Therapeutics ATHE
  5. Adhera Therapeutics ATRX